Cervical cancer is one of the three major cancers of women’s reproductive system, and the incidence of cervical cancer is gradually increasing. It has seriously endangered the life and health of women. Cervical cancer can be divided into cervical squamous carcinoma and cervical adenocarcinoma according to different histopathology. Among them, cervical adenocarcinoma is less common and its malignancy is relatively higher. The cure rate of cervical adenocarcinoma is determined by the stage of cervical adenocarcinoma at the time of detection. If cervical adenocarcinoma is detected at an early stage and the lesion is confined to the epithelial tissue of the cervix, then it can be treated by surgical excision. Patients have a higher five-year survival rate after surgery. The next treatment plan can then be decided based on the pathological results after surgery. The next treatment plan can include radiotherapy, chemotherapy, etc. Additional adjuvant treatments such as radiotherapy can kill the residual cancer cells, reduce the recurrence of cancer and prolong the patient’s life. If cervical cancer is detected at a later stage, the patient’s survival time is greatly reduced. Only very early stage cervical cancer can be completely cured. At present, various treatments can be used to prolong the survival time and improve the quality of life of patients with mid to late stage cervical cancer.